The Food and Drug Administration granted emergency use authorization Wednesday for a third dose of Pfizer and BioNTech's COVID-19 vaccine to be given to three groups.
The Food and Drug Administration granted emergency use authorization Wednesday for a third dose of Pfizer and BioNTech'sto be given to three groups — those 65 and older, those at high risk of developing severe COVID-19 and those at risk of developing "serious complications" due to "frequent institutional or occupational exposure," likely including frontline health care workers and those in prisons.
That group, the CDC Advisory Committee on Immunization Practices, met Wednesday to discuss the potential use of Pfizer's booster shots. It reviewed safety data collected from the millions of Americans who have already received additional doses of vaccine. Pfizer and its German partner BioNTech had initially sought full approval of its booster shot doses in all adults and teenagers at least 16 years old, citing promising data from its own trials and other countries that have administered third doses. to the ACIP underscoring waning vaccine effectiveness against symptomatic infection in the face of the Delta variant, and potentially against severe COVID-19 among older adults.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA backs Pfizer COVID-19 boosters for seniors and those at high riskThe FDA authorized Pfizer booster doses for Americans who are 65 and older, younger people with underlying health conditions and those in jobs that put them at high-risk for COVID-19.
Read more »
FDA authorizes Pfizer-BioNTech booster shot for elderly, people at high risk of severe Covid-19Pfizer-BioNTech booster shots are now authorized by the FDA for people 65 and older and for certain high-risk adult populations
Read more »
U.S. FDA clears Pfizer COVID-19 booster for older and at-risk AmericansThe U.S. Food and Drug Administration on Wednesday authorized a booster dose of the Pfizer Inc and BioNTech COVID-19 vaccine for those 65 and older, all people at high risk of severe disease, and others who are regularly exposed to the virus.
Read more »
Covid-19: NI records four Covid-linked deaths, 1,060 casesThe total number of deaths linked to coronavirus in NI since the start of the pandemic is 2,517.
Read more »
Pfizer Study of Covid-19 Vaccine in Pregnant Women Delayed by Slow EnrollmentPfizer wanted to study its Covid-19 vaccine in pregnant women, but then the shots became widely available; “It’s hard to enthusiastically recommend the study when you’ve got a vaccine out there,” says one doctor
Read more »
U.S. CDC advisers could vote on Pfizer COVID-19 vaccine booster on ThursdayThe CDC's Advisory Committee on Immunization Practices (ACIP) is meeting on Sept 22-23 to discuss which Americans should get the third vaccine shot, should it be authorized for use by the Food and Drug Administration. Pfizer has asked the FDA to approve the third shot for all people aged 16 and over, but a panel of outside advisors to the FDA last Friday said there was only evidence for a shot being needed by people aged 65 and older.
Read more »